J. Selam

Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience.

H Gin, B Catargi, B Guerci, 2003, Diabetes & metabolism.

Insulin detemir used in basal‐bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin

S. Skeie, E. Draeger, I. D. De Leeuw, 2005, Diabetes, obesity & metabolism.